J&J Appeals Invalidity Ruling For Stent Patents

By Brendan Pierson

Law360, New York (February 18, 2010, 1:11 PM ET) -- Johnson & Johnson Inc. has appealed a federal court's ruling in favor of plaintiff Boston Scientific Corp. that four of J&J's patents for drug-eluting stents are invalid.

According to the notice of appeal, filed Wednesday in the U.S. District Court for the District of Delaware, J&J will ask the U.S. Court of Appeals for the Federal Circuit to reverse the district court's orders construing J&J's patents and granting BSC summary judgment of invalidity.

Attorneys for the parties could not immediately be reached for comment on Thursday....
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles